SI1185293T1 - Il6ril6 chimera for the treatment of neurodegenerative diseases - Google Patents

Il6ril6 chimera for the treatment of neurodegenerative diseases

Info

Publication number
SI1185293T1
SI1185293T1 SI200030760T SI200030760T SI1185293T1 SI 1185293 T1 SI1185293 T1 SI 1185293T1 SI 200030760 T SI200030760 T SI 200030760T SI 200030760 T SI200030760 T SI 200030760T SI 1185293 T1 SI1185293 T1 SI 1185293T1
Authority
SI
Slovenia
Prior art keywords
treatment
neurodegenerative diseases
il6ril6 chimera
il6ril6
chimera
Prior art date
Application number
SI200030760T
Other languages
Slovenian (sl)
Inventor
Michel Revel
Judith Chebath
Marina Pizzi
Pierfranco Spano
Ursula Boschert
Original Assignee
Yeda Res & Dev
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL13058699A external-priority patent/IL130586A0/en
Application filed by Yeda Res & Dev, Applied Research Systems filed Critical Yeda Res & Dev
Publication of SI1185293T1 publication Critical patent/SI1185293T1/en

Links

SI200030760T 1999-06-21 2000-06-21 Il6ril6 chimera for the treatment of neurodegenerative diseases SI1185293T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13058699A IL130586A0 (en) 1999-06-21 1999-06-21 IL6RIL6 chimera for the treatment of demyelinating diseases
EP00939022A EP1185293B1 (en) 1999-06-21 2000-06-21 Il6ril6 chimera for the treatment of neurodegenerative diseases
PCT/IL2000/000363 WO2000078331A2 (en) 1999-06-21 2000-06-21 Il6ril6 chimera for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
SI1185293T1 true SI1185293T1 (en) 2006-02-28

Family

ID=35953486

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030760T SI1185293T1 (en) 1999-06-21 2000-06-21 Il6ril6 chimera for the treatment of neurodegenerative diseases

Country Status (1)

Country Link
SI (1) SI1185293T1 (en)

Similar Documents

Publication Publication Date Title
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL145470A0 (en) Compositions for the treatment of immune diseases
IL196301A0 (en) Medicament for the treatment of hapatitis c
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GB0010669D0 (en) Compositions for treatment of disorders of the oesophagus
EP1463527A4 (en) The use of gammaglobulin for the treatment of immune-mediated diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL153831A (en) Pharmaceutical composition for therapy of neurodegenerative disease of the brain
AU2266801A (en) Combination therapy for treating neurodegenerative disease
HK1038510B (en) Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
AU4215499A (en) Treatment of neurodegenerative diseases
PL373490A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
GB9900222D0 (en) Therapeutic compounds
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU6274101A (en) Medicines for the prevention and treatment of neurodegenerative diseases
SI1185293T1 (en) Il6ril6 chimera for the treatment of neurodegenerative diseases
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
GB9904252D0 (en) Composition for the treatment of pain
AU5854799A (en) Novel treatment of neurodegenerative diseases
IL147188A0 (en) Il6ril6 chimera for the treatment of demyelinating diseases
AU2002344959A1 (en) Use of fasl for the treatment of neurodegenerative diseases
SI1200447T1 (en) Oxazinocarbazoles for the treatment of cns diseases
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases